Organogenesis, Inc.June 8, 2018

FDA 483 - Organogenesis, Inc. - June 08, 2018

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Organogenesis, Inc.

Record Details

An FDA inspection of Organogenesis, Inc. in Canton, MA, a medical device manufacturer, revealed a significant issue regarding the establishment of requirements for suppliers and contractors. Specifically, the firm failed to adequately define the tests conducted by its contract laboratory for received tissues, leading to inconsistencies in documentation. This indicates a moderate severity issue related to quality control and supplier management.

Company: Organogenesis, Inc.
Inspection Date: June 8, 2018
Product Type: Device
Office: Division of Northeast Imports
Person: Elizabeth B. Griffin (Engineer/Investigator)

Open in Dashboard

ID · ce2270e3-62b8-458d-9672-6a5afec21ad9